Ebos drags NZX50 higher as healthcare stocks find favour

Paul McBeth
Wed, 22 Dec 2021

Paul McBeth
Wed, 22 Dec 2021
Ebos Group led the S&P/NZX 50 Index higher as healthcare stocks found themselves in favour as the omicron variant of covid-19 has investors pondering the next step in the pandemic.The benchmark index edged up 8.35 points, or 0.1%, to 12,865.22 in relatively modest trading, with turnover across the entire market of $111.5 million.Ebos rose 3.8% to $39.17 and is up 40.4% so far this year as investors continue to laud the animal and healthcare products manufacturer’s nous for acquisitions. Ebos is finishing off the retail component of ra...

Not convinced yet?

Subscribe to our Daily News Update free newsletter.

The Economist
How attractively are shares now priced?
The Economist | Sun, 26 Jun 2022

What a key valuation measure says about buying the dip.

The $100 Club: A wine rich list
Bob Campbell MW | Sun, 26 Jun 2022

If you're a wine connoisseur, you're spoiled for choice. The number of high-flying wines on sale for more than $100 has tripled since 2013.

Property FREE
Money Answers: how much mortgage can I actually afford?
Frances Cook | Sat, 25 Jun 2022

This week, readers ask how they should decide as a family what they can afford in terms of buying a house – and just because you can, should you?

Investments to sustain the momentum of building in NZ

Classic Capital has opened its Land & Build fund to qualified wholesale and eligible investors.

High water marks: Watercare raises the tide on sustainability

The No.1 barrier to decarbonisation for NZ organisations is accurate measurement, says Microsoft’s Accelerating the Journey to Net Zero report.